Patent · US Active

Synthesis of 1,4-diazaspiro[5.5]undecan-3-one

US12264135B2 · kind B2 · utility

0Cited by
5References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 24, 2023
Grant dateApr 1, 2025
Priority date
Expiry dateJul 24, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D239/47
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This invention provides a process for preparing 1,4-diazaspiro[5.5]undecan-3-one and analogues thereof that are useful in the preparation of pharmaceutical compound, including for the treatment of disorders involving abnormal cellular proliferation. Chemical intermediates in the process are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.